Hsp90β inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy

Abstract The loss of glutamate transporter-1 (GLT-1) is associated with temporal lobe epilepsy (TLE). A recent study reported that Hsp90β interacted with GLT-1 and recruited it to 20S proteasome for degradation. Therefore, inhibiting Hsp90β may be a new strategy for treating epilepsy. So far, no studies have shown whether the inhibition of Hsp90β had therapeutic effects on absence epilepsy. Using a model of absence epilepsy, we demonstrated that 17-allylamino-17-demethoxygeldanamycin (17AAG) and Ganetespib (STA9090) had no therapeutic effect. Although this is a negative result, it also has a meaningful exploration value for whether Hsp90 inhibitors have therapeutic effects on other epilepsy types. Graphical Abstract

[1]  G. Brockmann,et al.  Arch , 2020, Definitions.

[2]  김창호,et al.  35. , 1991, Maxime Planoudes, Lettres.

[3]  J. Park,et al.  Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model. , 2017, Anticancer research.

[4]  Harry Lee,et al.  Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling , 2017, International journal of oncology.

[5]  Yan Shen,et al.  Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy , 2017, The Journal of experimental medicine.

[6]  T. Kjaer,et al.  Detection of Paroxysms in Long-Term, Single-Channel EEG-Monitoring of Patients with Typical Absence Seizures , 2017, IEEE Journal of Translational Engineering in Health and Medicine.

[7]  G. G. Regner,et al.  Behavioral and genotoxic evaluation of rosmarinic and caffeic acid in acute seizure models induced by pentylenetetrazole and pilocarpine in mice , 2016, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  M. Carles,et al.  A pharmacological basis of herbal medicines for epilepsy , 2015, Epilepsy & Behavior.

[9]  L. Medina-Ceja,et al.  Effect of sparteine on status epilepticus induced in rats by pentylenetetrazole, pilocarpine and kainic acid , 2015, Brain Research.

[10]  M. Glicksman,et al.  Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease , 2015, The Journal of experimental medicine.

[11]  H. Sontheimer,et al.  Reactive Astrogliosis Causes the Development of Spontaneous Seizures , 2015, The Journal of Neuroscience.

[12]  L. Héja,et al.  Astrocytic target mechanisms in epilepsy. , 2014, Current medicinal chemistry.

[13]  R. Vandenberg,et al.  Mechanisms of glutamate transport. , 2013, Physiological reviews.

[14]  Jeffrey R Tenney,et al.  The Current State of Absence Epilepsy: Can We Have Your Attention? , 2013, Epilepsy currents.

[15]  O. Yalçin Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies , 2012, Seizure.

[16]  Yi-Song Wang,et al.  STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer. , 2010, Current opinion in investigational drugs.

[17]  D. Hirtz,et al.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. , 2010, The New England journal of medicine.

[18]  P. Ossenblok,et al.  Onset and propagation of spike and slow wave discharges in human absence epilepsy: A MEG study , 2009, Epilepsia.

[19]  C. Panayiotopoulos,et al.  Typical absence seizures and related epileptic syndromes: Assessment of current state and directions for future research , 2008, Epilepsia.

[20]  Gregory L. Holmes,et al.  Animal model studies application to human patients , 2007, Neurology.

[21]  I. Scheffer,et al.  Electroclinical features of absence seizures in childhood absence epilepsy , 2006, Neurology.

[22]  S. Lindquist,et al.  HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.

[23]  G. Holmes,et al.  Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children , 1999, Epilepsia.

[24]  Dreifuss Fe,et al.  Automatisms associated with the absence of petit mal epilepsy. , 1969 .

[25]  D. Daly Reflections on the Concept of Petit Mai , 1968, Epilepsia.

[26]  W. Lennox The heredity of epilepsy as told by relatives and twins. , 1951, Journal of the American Medical Association.